11.08.2016 • News

Philippe Saudan Chief Development Officer at Kuros

Kuros Biosciences has appointed Dr. Philippe Saudan as chief development officer and member of the executive board with immediate effect. With a PhD in biology from the University of Lausanne, Switzerland, and a 16 year-career in the pharmaceutical industry, Saudan has held management roles in R&D and last served as Chief Scientific Officer of Cytos Biotechnology. Since February 2016, he has been working as Head of Integration at Kuros.

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.